Trailing-twelve-month (TTM) revenue is $18.84 Billion with a year-over-year growth of +7.80%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $4,657,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-31 |
| Q4 FY2025Period ended 2025-12-31 | $4,425,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $4,742,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $5,021,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $18,845,000,000 |
Current P/S: $60,334,566,827 market capitalization ÷ $18,845,000,000 TTM revenue = 3.20x.
Market capitalization source: FMP quote. Quote observed 2026-09-24T18:45:20.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $5.02B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T18:45:55.309Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USDDisclosure unavailable | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Endless Assortment | N/A | $2.6B | $2.8B | $2.9B | $3.1B | $3.6B |
| High-Touch Solutions (N.A.) | N/A | $10.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| CANADA | $494M | $560M | $621M | $646M | $661M | $683M |
| JAPAN | N/A | $1.7B | $1.7B | $1.8B |
$18.84B
$18.84 Billion
+7.80%
vs. $17.48B a year ago (TTM)
+9.00%
5 Year compound annual growth rate
1 Year
+7.80%
3 Year
+5.57%
5 Year
+9.00%
10 Year
+6.46%
15 Year
+6.23%
20 Year
+6.14%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $17.94B | +$774.00M | +4.51% |
| 2024 | $17.17B | +$690.00M | +4.19% |
| 2023 | $16.48B | +$1.25B | +8.21% |
| 2022 | $15.23B | +$2.21B | +16.94% |
| 2021 | $13.02B | +$1.23B | +10.38% |
| 2020 |
TTM Growth
+7.80%
3-Year CAGR
+5.57%
5-Year CAGR
+9.00%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-24T18:45:55.309Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $12.2B |
| $13.3B |
| $13.7B |
| $14.0B |
| $2.2B |
| Other Foreign Countries | $2.1B | $521M | $563M | $646M | $667M | $645M |
|---|
| UNITED STATES | $9.2B | $10.2B | $12.3B | $13.4B | $13.9B | $14.4B |
|---|
| $11.80B |
| +$311.00M |
| +2.71% |
| 2019 | $11.49B | +$265.00M | +2.36% |
| 2018 | $11.22B | +$796.14M | +7.64% |
| 2017 | $10.42B | +$287.65M | +2.84% |
| 2016 | $10.14B | +$163.82M | +1.64% |
